NDC 80425-0100-01 - Alprazolam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0100
- Requested NDC
- 80425-0100-01
- Package NDCs from labels
- 80425-0100-2, 80425-0100-1, 80425-0100-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-07-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Alprazolam - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-07-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0100-1 | Alprazolam | 30 in 1 BOTTLE | TABLET | 30 | 7 | |
| 80425-0100-2 | Alprazolam | 60 in 1 BOTTLE | TABLET | 60 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0100 | ALPRAZOLAM TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20240712_b39e2bc8-b691-0f4e-e053-2995a90a00fd.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0100-1 | EA - Each | 80425-0100 | 1bc798ae-2e69-4efa-b20e-0b9b2681b48b | 1 | 2024-08-12 |
| 80425-0100-2 | EA - Each | 80425-0100 | 7e0d1fd1-cf9b-4191-9d35-098800a7e2f6 | 1 | 2023-03-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alprazolam | ALPRAZOLAM | A-S Medication Solutions | 8ef75d22-4a7c-48d5-a532-5a43b8593e7c | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | 308048 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | Natco Pharma USA LLC | b3c55877-2538-4892-bdb1-d618c643d29c | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | 197321 308047 197322 308048 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | Northwind Health Company, LLC | 25174ee5-a86e-ab97-e063-6394a90acd87 | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | 308047 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | Aurobindo Pharma Limited | d2fd0b3e-9b78-44d0-82a6-96d6c6238750 | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | 197321 308047 197322 308048 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | Aurobindo Pharma Limited | 326fa31a-5420-429b-9f7f-170cb38f64bd | 2025-12-11 | Boxed warning, Warnings, Adverse reactions | YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | PD-Rx Pharmaceuticals, Inc. | 5040e1ed-32d6-4757-a0ee-b8240f3e7cf5 | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 308048 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | PD-Rx Pharmaceuticals, Inc. | 2f16ff78-1262-4bb8-9a25-822c13c4746f | 2025-10-09 | Boxed warning, Warnings, Adverse reactions | 197321 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | AvPAK | 3fa14fa4-45a7-6ef4-e063-6394a90a1dcd | 2025-09-25 | Boxed warning, Warnings, Adverse reactions | 197321 308047 308048 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | A-S Medication Solutions | 3c0cb60f-1c3a-48a6-ad16-f14351548412 | 2025-07-10 | Boxed warning, Warnings, Adverse reactions | ANDA074112 197321 308047 197322 YU55MQ3IZY |
| Alprazolam C-IV | ALPRAZOLAM C-IV | Direct_Rx | f6dd0e94-4a79-769f-e053-6394a90a5ae6 | 2025-06-02 | Boxed warning, Warnings, Adverse reactions | 308048 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | NuCare Pharmaceuticals, Inc. | 315b5782-969a-4324-e063-6394a90acf37 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | 308047 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | NuCare Pharmaceuticals, Inc. | 315b8cf2-01a0-3f7d-e063-6394a90a39b5 | 2025-03-27 | Boxed warning, Warnings, Adverse reactions | 308048 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | PD-Rx Pharmaceuticals, Inc. | 0ffcdbab-17e4-4395-8155-5b6ad00be6c2 | 2025-02-28 | Boxed warning, Warnings, Adverse reactions | ANDA074112 197321 YU55MQ3IZY |
| Alprazolam XR | ALPRAZOLAM | Mylan Pharmaceuticals Inc. | 1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3 | 2025-02-11 | Boxed warning, Warnings, Adverse reactions | YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | Direct_Rx | f77cfdd0-847d-4edd-e053-6394a90a91b7 | 2025-01-22 | Boxed warning, Warnings, Adverse reactions | 197322 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | Mylan Pharmaceuticals Inc. | 13930c94-d83a-414f-be35-b1fef35f738d | 2025-01-15 | Boxed warning, Warnings, Adverse reactions | 197321 308047 197322 308048 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | NuCare Pharmaceuticals,Inc. | 02840ea6-e4a0-96a0-e063-6394a90a19ae | 2025-01-03 | Boxed warning, Warnings, Adverse reactions | 308047 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | PD-Rx Pharmaceuticals, Inc. | 7538d0d0-346e-4c3e-8f7a-c1cac8ec8ed3 | 2025-01-02 | Boxed warning, Warnings, Adverse reactions | 197322 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | Advanced Rx of Tennessee, LLC | b39e2bc8-b68f-0f4e-e053-2995a90a00fd | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 308048 YU55MQ3IZY |
| Alprazolam | ALPRAZOLAM | Advanced Rx of Tennessee, LLC | b4cd647f-1ba3-334e-e053-2995a90af352 | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 197321 YU55MQ3IZY |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.